MGMatthew F. Giles

Matthew F. Giles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew F. Giles has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID−TIA): study protocol for a pilot randomised controlled trial

    by Duncan Edwards, Kate Fletcher, Rachel Deller, Richard McManus, Daniel Lasserson, Matthew Giles, Don Sims, John Norrie, Graham McGuire, Simon Cohn, et al.

    Background: People who have a transient ischaemic attack (TIA) or minor stroke are at high risk of a recurrent stroke, particularly in the first week after the event. Early initiation of secondary prevention drugs is associated with an 80% reduction in risk of stroke recurrence. This raises the question as to whether these drugs should be given before being seen by a specialist – that is, in primary care or in the emergency department. The aims of the RAPID-TIA pilot trial are to determine the feasibility of a randomised controlled trial, to analyse cost effectiveness and to ask: Should general practitioners and emergency doctors (primary care physicians) initiate secondary preventative measures in addition to aspirin in people they see with suspected TIA or minor stroke at the time of referral to a specialist? Methods/Design: This is a pilot randomised controlled trial with a sub-study of accuracy of primary care physician diagnosis of TIA. In the pilot trial, we aim to recruit 100 patients from 30 general practices (including out-of-hours general practice centres) and 1 emergency department whom the primary care physician diagnoses with TIA or minor stroke and randomly assign them to usual care (that is, initiation of aspirin and referral to a TIA clinic) or usual care plus additional early initiation of secondary prevention drugs (a blood-pressure lowering protocol, simvastatin 40 mg and dipyridamole 200 mg m/r bd). The primary outcome of the main study will be the number of strokes at 90 days. The diagnostic accuracy sub-study will include these 100 patients and an additional 70 patients in whom the primary care physician thinks the diagnosis of TIA is possible, rather than probable. For the pilot trial, we will report recruitment rate, follow-up rate, a preliminary estimate of the primary event rate and occurrence of any adverse events. For the diagnostic study, we will calculate sensitivity and specificity of primary care physician diagnosis using the final TIA clinic diagnosis as the reference standard. Discussion: This pilot study will be used to estimate key parameters that are needed to design the main study and to estimate the accuracy of primary care diagnosis of TIA. The planned follow-on trial will have important implications for the initial management of people with suspected TIA. Trial registration: ISRCTN62019087


  • Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA

    by M.F. Giles, G.W. Albers, P. Amarenco, E.M. Arsava, A.W. Asimos, H. Ay, D. Calvet, S.B. Coutts, B.L. Cucchiara, A.M. Demchuk, et al.

    Objectives: Stroke risk immediately after TIA defined by time-based criteria is high, and prognostic scores (ABCD2 and ABCD3-I) have been developed to assist management. The American Stroke Association has proposed changing the criteria for the distinction between TIA and stroke from time-based to tissue-based. Research using these definitions is lacking. In a multicenter observational cohort study, we have investigated prognosis and performance of the ABCD2 score in TIA, subcategorized as tissue-positive or tissue-negative on diffusion-weighted imaging (DWI) or CT imaging according to the newly proposed criteria. Methods: Twelve centers provided data on ABCD2 scores, DWI or CT brain imaging, and follow-up in cohorts of patients with TIA diagnosed by time-based criteria. Stroke rates at 7 and 90 days were studied in relation to tissue-positive or tissue-negative subcategorization, according to the presence or absence of brain infarction. The predictive power of the ABCD2 score was determined using area under receiver operator characteristic curve (AUC) analyses. Results: A total of 4,574 patients were included. Among DWI patients (n = 3,206), recurrent stroke rates at 7 days were 7.1%(95% confidence interval 5.5–9.1) after tissue-positive and 0.4% (0.2–0.7) after tissue-negative events (p diff < 0.0001). Corresponding rates in CT-imaged patients were 12.8% (9.3–17.4) and 3.0% (2.0–4.2), respectively (p diff < 0.0001). The ABCD2 score had predictive value in tissue-positive and tissue-negative events (AUC = 0.68 [95% confidence interval 0.63–0.73] and 0.73 [0.67–0.80], respectively; p sig < 0.0001 for both results, p diff = 0.17). Tissue-positive events with low ABCD2 scores and tissue-negative events with high ABCD2 scores had similar stroke risks, especially after a 90-day follow-up. Conclusions: Our findings support the concept of a tissue-based definition of TIA and stroke, at least on prognostic grounds.


  • Addition of Brain Infarction to the ABCD 2 Score (ABCD 2 I)

    by Matthew F. Giles, Greg W. Albers, Pierre Amarenco, Murat M. Arsava, Andrew Asimos, Hakan Ay, David Calvet, Shelagh Coutts, Brett L. Cucchiara, Andrew M. Demchuk, et al.

    Background and Purpose— The ABCD system was developed to predict early stroke risk after transient ischemic attack. Incorporation of brain imaging findings has been suggested, but reports have used inconsistent methods and been underpowered. We therefore performed an international, multicenter collaborative study of the prognostic performance of the ABCD 2 score and brain infarction on imaging to determine the optimal weighting of infarction in the score (ABCD 2 I). Methods— Twelve centers provided unpublished data on ABCD 2 scores, presence of brain infarction on either diffusion-weighted imaging or CT, and follow-up in cohorts of patients with transient ischemic attack diagnosed by World Health Organization criteria. Optimal weighting of infarction in the ABCD 2 I score was determined using area under the receiver operating characteristic curve analyses and random effects meta-analysis. Results— Among 4574 patients with TIA, acute infarction was present in 884 (27.6%) of 3206 imaged with diffusion-weighted imaging and new or old infarction was present in 327 (23.9%) of 1368 imaged with CT. ABCD 2 score and presence of infarction on diffusion-weighted imaging or CT were both independently predictive of stroke (n=145) at 7 days (after adjustment for ABCD 2 score, OR for infarction=6.2, 95% CI=4.2 to 9.0, overall; 14.9, 7.4 to 30.2, for diffusion-weighted imaging; 4.2, 2.6 to 6.9, for CT; all P 2 I score improved predictive power with an optimal weighting of 3 points for infarction on CT or diffusion-weighted imaging. Pooled areas under the curve increased from 0.66 (0.53 to 0.78) for the ABCD 2 score to 0.78 (0.72 to 0.85) for the ABCD 2 I score. Conclusions— In secondary care, incorporation of brain infarction into the ABCD system (ABCD 2 I score) improves prediction of stroke in the acute phase after transient ischemic attack.


  • Systematic Review and Pooled Analysis of Published and Unpublished Validations of the ABCD and ABCD2 Transient Ischemic Attack Risk Scores

    by Matthew F. Giles, Peter M. Rothwell

    Background and Purpose— The ABCD system was derived to predict early risk of stroke after transient ischemic attack. Independent validations have reported conflicting results. We therefore systematically reviewed published and unpublished data to determine predictive value and generalizability to different clinical settings and users. Methods— Validations of the ABCD and ABCD2 scores were identified by searching electronic databases, reference lists, relevant journals, and conference abstracts. Unpublished tabulated data were obtained where available. Predictive value, expressed as pooled areas under the receiver operator characteristic curves (AUC), was calculated using random-effects meta-analysis, and analyses for heterogeneity were performed by categorization according to study setting and method. Results— Twenty cohorts were identified reporting the performance of the ABCD system in 9808 subjects with 456 strokes at 7 days. Among the 16 studies of both the ABCD and ABCD2 scores, pooled AUC for the prediction of stroke at 7 days were 0.72 (0.66 to 0.78) and 0.72 (0.63 to 0.82), respectively ( P diff=0.97). The pooled AUC for the ABCD and ABCD2 scores in all cohorts reporting relevant data were 0.72 (0.67 to 0.77) and 0.72 (0.63 to 0.80), respectively (both P P Conclusion— Independent validations of the ABCD system showed good predictive value, with the exception of studies based on retrospective extraction of nonsystematically collected data from emergency department records.


  • Transient Ischaemic Attack - Obtaining a Differential Diagnosis and Predicting Patient Risk

    by Matthew F Giles

    Transient ischaemic attack (TIA) is common and the total number of TIAs is likely to increase with the ageing of the population. It is a heterogeneous condition with a range of possible presentations, making diagnosis challenging. The differential diagnosis includes other serious conditions, so accurate, early diagnosis is important. The risk of stroke early after TIA has recently been shown to be approximately 5% at seven days and 10–15% at three months, while overall cardiovascular risk is increased in the longer term. The ABCD 2 score is a prediction tool that can be rapidly applied at the time of presentation and reliably predicts early risk of stroke. The vascular territory, aetiology of TIA and findings on cerebral imaging can also be used to predict early risk of stroke, but the degree of interaction between all these factors is uncertain.


  • Vascular cognitive impairment: investigation and treatment

    by Sarah T. Pendlebury, Matthew F. Giles, Peter M. Rothwell

  • Vascular cognitive impairment: definitions and clinical diagnosis

    by Sarah T. Pendlebury, Matthew F. Giles, Peter M. Rothwell

  • Spontaneous subarachnoid hemorrhage

    by Sarah T. Pendlebury, Matthew F. Giles, Peter M. Rothwell

  • Intervention for asymptomatic carotid stenosis

    by Sarah T. Pendlebury, Matthew F. Giles, Peter M. Rothwell